S061 The Best of American and European Dermatology
DESCRIPTION
The EADV and AAD have joined forces in an effort to complement one another and provide the audience with an expanded perspective on topics of interest to dermatologists from true experts from both sides of the Atlantic Ocean. Speakers will discuss a diverse group of topics and their impact in caring for our patients. We will hear about Urethritis, Pyoderma Gangrenosum, Severe Drug Reactions, Granulomatous Disease, Psoriasis and Precision Medicine.
LEARNING OBJECTIVES
Diagnose patients with Urethritis, Pyoderma Gangrenosum, Severe Drug Reactions, Granulomatous Disease, Psoriasis and understand Precision Medicine
Construct an appropriate evaluation and management for patients with Urethritis, Pyoderma Gangrenosum, Severe Drug Reactions, Granulomatous Disease, Psoriasis and utilize Precision Medicine
SCHEDULE
1:00 PM
Introduction
Robert S. Kirsner, MD, PhD, FAAD
1:05 PM
What’s New in Granulomatous Disease
Misha Rosenbach, MD, FAAD
1:30 PM
Severe Drug Eruptions
Lars French, MD, IFAAD
1:55 PM
Update on Pyoderma Gangrenosum
Alex Gerardo Ortega-Loayza, MD, FAAD
2:20 PM
Diagnosis and management of Urethritis
2:45 PM
Can we cure psoriasis?
Andrew Blauvelt, MD, FAAD
3:10 PM
Precision medicine in Dermatology
Michel F Gilliet, MD
3:35 PM
Summary & Wrap Up
Michel F Gilliet, MD
DIRECTOR
Robert S. Kirsner, MD, PhD, FAAD
SPEAKERS
Andrew Blauvelt, MD, FAAD
Lars French, MD, IFAAD
Michel F Gilliet, MD
Alex Gerardo Ortega-Loayza, MD, FAAD
Misha Rosenbach, MD, FAAD
Georg Stary, MD
DISCLOSURES
Andrew Blauvelt, MD, FAAD
AbbVie – Consultant(Honoraria); Almirall – Consultant(Honoraria), Speaker(Honoraria); Alumis – Consultant (1099 relationship)(Honoraria); Amgen – Consultant (1099 relationship)(Honoraria); AnaptysBio – Consultant (1099 relationship)(Honoraria); Apogee Therapeutics – Consultant (1099 relationship)(Honoraria); Arcutis, Inc. – Consultant (1099 relationship)(Honoraria); Eli Lilly and Company – Consultant(Honoraria), Speaker(Honoraria); Incyte Corporation – Consultant(Honoraria); Janssen-Ortho Inc. – Consultant(Honoraria); Leo Pharma – Speaker(Honoraria); Leo Pharma Inc – Consultant(Honoraria); Lipidio Pharmaceuticals – Stockholder Private Company(Stock); Novartis Pharmaceuticals Corp. – Consultant(Honoraria); Oruka Therapeutics – Consultant (1099 relationship)(Honoraria), Stockholder Public Company(Stock); Pfizer Inc. – Consultant(Honoraria); Regeneron – Consultant(Honoraria); Sanofi – Consultant(Honoraria), Speaker(Honoraria); Sun Pharmaceutical Industries Ltd. – Consultant(Honoraria); Takeda Pharmaceuticals USA Inc – Consultant (1099 relationship)(Honoraria); UCB – Consultant(Honoraria), Speaker(Honoraria);
Lars French, MD, IFAAD
AC Immune – Investigator(Grants/Research Funding); Almirall – Consultant(Honoraria); Alys Pharmaceuticals – Advisory Board(Honoraria); Biotest Pharmaceuticals Corporation – Advisory Board(Honoraria); Janssen-Cilag – Advisory Board(Honoraria); Leo Pharma A/S – Advisory Board(Honoraria); Pincell – Advisory Board(Honoraria); UCB – Advisory Board(Honoraria); Union Therapeutics – Advisory Board(Honoraria); Vaderis Therapeutics – Data Safety Monitoring Board(Honoraria);
Michel F Gilliet, MD
AbbVie – Investigator(Honoraria); Almirall – Investigator(Grants/Research Funding); Amgen – Investigator(Grants/Research Funding); AVVA Pharmaceuticals Ltd – Investigator(Grants/Research Funding); Dermapharm AG – Investigator(Grants/Research Funding); Eli Lilly – Investigator(Grants/Research Funding); Kyowa Kirin – Investigator(Grants/Research Funding); L'Oréal Suisse SA – Investigator(Grants/Research Funding); Leo Pharma Inc – Investigator(Grants/Research Funding); Merz Pharma AG – Investigator(Grants/Research Funding); Nogra Pharma Ltd – Investigator(Grants/Research Funding); Novartis Pharmaceuticals Corp. – Investigator(Grants/Research Funding); Permamed AG – Investigator(Grants/Research Funding); Pierre Fabre – Investigator(Grants/Research Funding); Sanofi – Investigator(Honoraria); UCB – Investigator(Grants/Research Funding); Ultrasun AG – Investigator(Grants/Research Funding); Verfora SA – Investigator(Grants/Research Funding); Wellzia – Investigator(Grants/Research Funding);
Robert S. Kirsner, MD, PhD, FAAD
Boehringer Ingelheim – Investigator(Grants/Research Funding); BPGbio – Consultant (1099 relationship)(Honoraria); Hoth Therapeutics – Investigator(Grants/Research Funding); Kerecis Limited – Advisory Board(Honoraria); MediWound – Investigator(Grants/Research Funding); molnlycke – Advisory Board(Honoraria); Organogenesis, Inc. – Advisory Board(Honoraria); Pfizer Inc. – Advisory Board(Honoraria); Smith & Nephew – Advisory Board(Honoraria); SolasCure – Consultant (1099 relationship)(Honoraria); Tempo therapeutics – Consultant (1099 relationship)(Honoraria); Urgo Group – Advisory Board(Honoraria);
Alex Gerardo Ortega-Loayza, MD, FAAD
AbbVie – Investigator(Grants/Research Funding); Almirall – Consultant (1099 relationship)(Fees); Boehringer Ingelheim – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Bristol Myers Squibb – Advisory Board(Honoraria); Castle Biosciences – Consultant (1099 relationship)(Fees); Clarivate – Consultant (1099 relationship)(Fees); Corvus Pharmaceuticals – Consultant (1099 relationship)(Fees); Eli Lilly – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); EPI-Q Inc – Consultant (1099 relationship)(Fees); Genentech – Consultant (1099 relationship)(Fees); Guidepoint Global, LLC – Consultant (1099 relationship)(Fees); Incyte – Investigator(Grants/Research Funding); InflaRx GmbH – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Janssen – Investigator(Grants/Research Funding); Janssen Biotech – Advisory Board(Honoraria); Janssen Research & Development, LLC – Advisory Board(Honoraria); Otsuka Pharmaceutical Co., Ltd. – Consultant (1099 relationship)(Fees); Pfizer Inc. – Investigator(Grants/Research Funding); Sanofi – Advisory Board(Honoraria); Sitala Bio Ltd – Consultant (1099 relationship)(Fees); TFS Health Science – Consultant (1099 relationship)(Fees); Visterra – Consultant (1099 relationship)(Fees);
Misha Rosenbach, MD, FAAD
J&J Innovative Medicine – Consultant(Honoraria); Merck & Co., Inc – Consultant(Honoraria); Novartis – Consultant(Honoraria); Priovant Therapeutics – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding);
Georg Stary, MD
AbbVie – Advisory Board(Fees); Almirall – Advisory Board(Grants/Research Funding); Janssen Pharmaceuticals, Inc – Advisory Board(Grants/Research Funding);